Managed Healthcare Executive July 21, 2022

The president of CVS Caremark discusses competition in the PBM industry, new entrants into the business, transparency and the reasons for establishing a group purchasing organization.

Second of three parts

Editor’s note: We interviewed Lotvin several weeks ago before the Federal Trade Commission announced its study of the PBM industry and before a whistleblower lawsuit was filed against the company An excerpt of the transcript of that interview ran in our June 2022 print issue

Here is secod segment of the full transcript, which has been edited lightly for clarity.

The industry has consolidated. We talk about the Big Three. It used to be the Big Five. As you know, CVS Caremark — your company — Express Scripts and OptumRx control...

Today's Sponsors

Amwell
Oliver Wyman
Upfront Healthcare

Today's Sponsors

Qure4u
H1

Today's Sponsor

HealthITq

 
Topics: Interview / Q&A, Pharma, Pharma / Biotech, Trends
Price and End Point. For Cancer Drugs, There Is a Disconnect, Research Finds
What makes a good (and bad) pharmaceutical forecast model
Integrating specialty pharmacists into health systems facilitates better care: study
If You Want to Know Where Pharmacists' Roles Are Heading, Follow Patients
Wearables Made for the Pharmaceutical Industry